Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 26, Issue 28, Pages 4036-4054
Publisher
Baishideng Publishing Group Inc.
Online
2020-07-28
DOI
10.3748/wjg.v26.i28.4036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis
- (2020) Shenghua Dong et al. Molecular Genetics & Genomic Medicine
- A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1
- (2020) Kim B. Luley et al. Cancers
- CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
- (2019) Nadia Habel et al. BMC CANCER
- Cyr61/CCN1 regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma
- (2019) Gargi Maity et al. MOLECULAR CANCER THERAPEUTICS
- Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality
- (2019) Junjun Wu et al. BMC CANCER
- The multifaceted roles of FOXM1 in pulmonary disease
- (2019) Yumei Li et al. Cell Communication and Signaling
- Temozolomide alone or combined to capecitabine for the treatment of advanced pancreatic NET
- (2019) Louis de Mestier et al. NEUROENDOCRINOLOGY
- Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens
- (2019) Stefano Partelli et al. NEUROENDOCRINOLOGY
- Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)
- (2019) Louis de Mestier et al. ANNALES D ENDOCRINOLOGIE
- Two well-differentiated pancreatic neuroendocrine tumor mouse models
- (2019) Chung Wong et al. CELL DEATH AND DIFFERENTIATION
- Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors
- (2019) Mohamad Bassam Sonbol et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours
- (2019) Christodoulos P Pipinikas et al. ENDOCRINE-RELATED CANCER
- The Molecular Biology of Pancreatic Neuroendocrine Neoplasms: Challenges and Translational Opportunities
- (2019) Kate Young et al. SEMINARS IN CANCER BIOLOGY
- Deep learning for World Health Organization grades of pancreatic neuroendocrine tumors on contrast-enhanced magnetic resonance images: a preliminary study
- (2019) Xuan Gao et al. International Journal of Computer Assisted Radiology and Surgery
- PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors
- (2019) Gabriel Mpilla et al. Cancers
- An update on the management of pancreatic neuroendocrine tumors
- (2018) Limin Gao et al. ANTI-CANCER DRUGS
- Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
- (2018) Ling Liu et al. Cell Metabolism
- The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
- (2018) Tobias Hofving et al. ENDOCRINE-RELATED CANCER
- Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms
- (2018) Federica Grillo et al. ENDOCRINE-RELATED CANCER
- PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
- (2018) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
- (2018) Mickaël Ohanna et al. GENES & DEVELOPMENT
- The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges
- (2018) Maria Dalamaga et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition
- (2018) Weixuan Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
- (2018) Daniel Benten et al. MOLECULAR CANCER RESEARCH
- A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
- (2018) Mariano J. Alvarez et al. NATURE GENETICS
- NAMPT: a pleiotropic modulator of monocytes and macrophages
- (2018) Cristina Travelli et al. PHARMACOLOGICAL RESEARCH
- Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
- (2018) Andrea Corsello et al. PLoS One
- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- Treatment options for PNET liver metastases: a systematic review
- (2018) Giuseppe Nigri et al. World Journal of Surgical Oncology
- Expression and functional characterization of FOXM1 in non-small cell lung cancer
- (2018) Yan Zhang et al. OncoTargets and Therapy
- Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study
- (2018) Ville J. Sallinen et al. HPB
- Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
- (2018) Jasper Edgar Neggers et al. Nature Communications
- Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation
- (2018) Dominik Kraus et al. CELLULAR ONCOLOGY
- The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study
- (2018) Shanshan Gao et al. Journal of Cancer
- Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
- (2018) Samantha Exner et al. Frontiers in Endocrinology
- Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
- (2018) W. A. van der Zwan et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-Resistant Tumors
- (2018) Chester E. Chamberlain et al. MOLECULAR CANCER THERAPEUTICS
- The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis
- (2018) J. Patrick Murphy et al. Cell Reports
- Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors
- (2018) Alessandra Pulvirenti et al. HPB
- Clinical Management of Malignant Insulinoma: a single Institution’s experience over three decades
- (2018) Jie Yu et al. BMC Endocrine Disorders
- Biological functions and role of CCN1/Cyr61 in embryogenesis and tumorigenesis in the female reproductive system (Review)
- (2017) Rui Yang et al. Molecular Medicine Reports
- Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
- (2017) Louis de Mestier et al. NEUROENDOCRINOLOGY
- Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1
- (2017) Robert T. Jensen et al. PANCREAS
- Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors
- (2017) Nancy Sharma et al. PANCREAS
- ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras
- (2017) Nicholas Blazanin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
- (2017) Jeffrey J. Rodvold et al. Science Signaling
- Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
- (2017) Yong Tang et al. OncoTargets and Therapy
- Molecular challenges of neuroendocrine tumors (Review)
- (2017) Parthik Patel et al. Oncology Letters
- Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel
- (2017) Ferga C. Gleeson et al. Oncotarget
- Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
- (2017) Jeffrey J. Rodvold et al. Science Signaling
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs
- (2017) Yang Lv et al. Endocrine Connections
- PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration
- (2017) Helen King et al. Scientific Reports
- A novel orally bioavailable compound KPT-9274 inhibits PAK4 and blocks triple negative breast cancer tumor growth
- (2017) Chetan Rane et al. Scientific Reports
- Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study
- (2016) S. Faivre et al. ANNALS OF ONCOLOGY
- Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls
- (2016) Paweł Gut et al. Archives of Medical Science
- GEP- NETS UPDATE: Genetics of neuroendocrine tumors
- (2016) Joakim Crona et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
- (2016) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets
- (2016) Ellinor Andersson et al. MODERN PATHOLOGY
- Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma
- (2016) Amro Aboukameel et al. MOLECULAR CANCER THERAPEUTICS
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors
- (2016) Robert A. Ramirez et al. ONCOLOGIST
- Prise en charge du gastrinome
- (2016) Elisabeth Hain et al. PRESSE MEDICALE
- The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells
- (2016) C.T.D. Kwok et al. Stem Cell Research
- Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation
- (2016) Liwei Meng et al. OncoTargets and Therapy
- Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-κB activation in HCAECs
- (2016) Kai-Lei Shi et al. Oncology Letters
- Pancreatic neuroendocrine tumors: Nosography, management and treatment
- (2016) Michele Orditura et al. International Journal of Surgery
- RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors
- (2016) Yonghe Wu et al. Oncotarget
- The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis
- (2016) Yu-Ting Huang et al. Oncotarget
- CCN family of proteins: critical modulators of the tumor cell microenvironment
- (2016) Herman Yeger et al. Journal of Cell Communication and Signaling
- Conditional Deletion ofMen1in the Pancreatic β-Cell Leads to Glucagon-Expressing Tumor Development
- (2015) Feng Li et al. ENDOCRINOLOGY
- Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
- (2015) Lisa-Marie Dilz et al. EUROPEAN JOURNAL OF CANCER
- Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies
- (2015) Ersin Gürkan Dumlu et al. INTERNATIONAL SURGERY
- p21-Activated Kinase 4 Critically Regulates Melanogenesis via Activation of the CREB/MITF and β-Catenin/MITF Pathways
- (2015) Cheong-Yong Yun et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1
- (2015) T. Vandamme et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Consensus on biomarkers for neuroendocrine tumour disease
- (2015) Kjell Oberg et al. LANCET ONCOLOGY
- Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management
- (2015) Jordan M Cloyd WORLD JOURNAL OF GASTROENTEROLOGY
- A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
- (2015) A. Sadanandam et al. Cancer Discovery
- The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression
- (2015) Yu-Ting Huang et al. Oncotarget
- FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors
- (2015) Franziska Briest et al. Oncotarget
- A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas
- (2015) Roberta L. Beauchamp et al. Oncotarget
- Genetics of pancreatic neuroendocrine tumors: implications for the clinic
- (2015) Antonio Pea et al. Expert Review of Gastroenterology & Hepatology
- Optimal Use of Biomarkers in Oncology
- (2015) Marie Karlikova et al. Biomed Research International
- Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
- (2014) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Inhibitors of p21-Activated Kinases (PAKs)
- (2014) Joachim Rudolph et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chromogranin A as a Marker for Diagnosis, Treatment, and Survival in Patients With Gastroenteropancreatic Neuroendocrine Neoplasm
- (2014) Yu-hong Wang et al. MEDICINE
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pancreatic cancer microenvironment: an immunologic battleground
- (2014) Venu G Pillarisetty OncoImmunology
- Modulation of pancreatic exocrine and endocrine secretion
- (2013) Rashmi Chandra et al. CURRENT OPINION IN GASTROENTEROLOGY
- P21-activated kinase 4 – Not just one of the PAK
- (2013) Anna E. Dart et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress
- (2013) Amanda Croft et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Animal Models and Cell Lines of Pancreatic Neuroendocrine Tumors
- (2013) Varsha Babu et al. PANCREAS
- Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
- (2013) Pamela L. Kunz et al. PANCREAS
- Diagnosis and management of insulinoma
- (2013) Takehiro Okabayashi WORLD JOURNAL OF GASTROENTEROLOGY
- The Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells
- (2013) L E Wong et al. Oncogenesis
- Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib
- (2013) Aaron I. Vinik et al. Therapeutic Advances in Gastroenterology
- ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
- (2012) Lori S. Hart et al. JOURNAL OF CLINICAL INVESTIGATION
- Knockdown of PAK4 or PAK1 Inhibits the Proliferation of Mutant KRAS Colon Cancer Cells Independently of RAF/MEK/ERK and PI3K/AKT Signaling
- (2012) H. Tabusa et al. MOLECULAR CANCER RESEARCH
- The Role of Cell Lines in the Study of Neuroendocrine Tumors
- (2012) Simona Grozinsky-Glasberg et al. NEUROENDOCRINOLOGY
- Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment
- (2012) Cynthia Ro et al. Chinese Journal of Cancer
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- Neuroendocrine Pancreatic Tumors: Guidelines for Management and Update
- (2011) William R. Burns et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis
- (2011) Inamul Haque et al. Molecular Cancer
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
- (2010) Irvin M. Modlin et al. ANNALS OF SURGICAL ONCOLOGY
- Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
- (2010) Marialuisa Appetecchia et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
- (2010) M. K. Y. Siu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via Pdx1-Directed Inactivation of Men1
- (2009) H.-C. J. Shen et al. CANCER RESEARCH
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer
- (2008) A. C. Kimmelman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nampt: linking NAD biology, metabolism and cancer
- (2008) Antje Garten et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer
- (2007) Krystyna Stec-Michalska et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started